BTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBudesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis.
More Information Supplier PageBudesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis.
More Information Supplier PageBupivacaine is a more potent inhibitor of cAMP production than are chemically related local anesthetics that are less prone to produce cardiovascular toxicity.
More Information Supplier PageBupivacaine is a more potent inhibitor of cAMP production than are chemically related local anesthetics that are less prone to produce cardiovascular toxicity.
More Information Supplier Page
